+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Plasma Fractionation Technology Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280682
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Blood Plasma Fractionation Technology: Executive Overview

Blood plasma fractionation technology separates plasma into therapeutically valuable proteins, including immunoglobulins, albumin, and coagulation factors. Its strategic importance is linked to the treatment of immune deficiencies, bleeding disorders, critical-care conditions, and other chronic diseases. The field combines donor collection, cold-chain logistics, viral safety, purification, formulation, quality control, and regulatory compliance, making operational resilience as important as laboratory performance.

How Plasma Fractionation Is Reshaping Biopharmaceutical Operations

The landscape is shifting toward higher process consistency, improved pathogen-reduction controls, more efficient plasma utilization, and tighter integration between collection centers, manufacturers, hospitals, and regulators. Advances in chromatography, membrane processing, automation, single-use equipment, and analytical characterization are supporting more controlled workflows. At the same time, donor recruitment, ethical collection practices, energy use, waste management, and supply continuity are becoming central strategic considerations.

Artificial Intelligence Across Plasma Collection and Manufacturing

Artificial intelligence can strengthen the sector by improving donor scheduling, screening workflow, inventory coordination, anomaly detection, predictive maintenance, and process monitoring. Machine-learning tools may also help identify deviations in purification steps and support faster review of quality data. These benefits depend on representative datasets, validated models, cybersecurity, human oversight, and compliance with applicable good-manufacturing and medical-device requirements. AI should therefore augment qualified personnel rather than replace scientific and clinical judgment.

Regional Insights Across Plasma Fractionation Ecosystems

North America combines established collection infrastructure with advanced bioprocessing and regulatory capabilities. Europe emphasizes harmonized quality systems, traceability, and coordinated health policy, while Latin America continues to focus on strengthening donation networks, local manufacturing capacity, and equitable access. Asia-Pacific is characterized by expanding healthcare demand, investment in biotechnology, and diverse regulatory environments. The Middle East is prioritizing healthcare-system modernization and supply security, and Africa’s principal opportunities involve donor access, laboratory capacity, cold-chain development, and resilient public-health partnerships.

Group-Level Priorities Across Major Economic and Security Blocs

ASEAN countries face the need to coordinate standards, logistics, and regional supply resilience across varied healthcare systems. BRICS members provide a broad platform for cooperation in domestic biomanufacturing, technology transfer, and public-health preparedness, although regulatory alignment remains uneven. The European Union benefits from integrated policy mechanisms and common quality expectations. G7 economies generally emphasize advanced research, pharmacovigilance, and supply-chain security. GCC states are concentrating on healthcare localization and specialized infrastructure, while NATO members increasingly treat medical supply continuity and critical manufacturing capacity as components of broader resilience planning.

Country-Level Signals Shaping Technology Adoption

Australia is focused on reliable access across a geographically dispersed system. Brazil and Mexico are strengthening domestic capacity while addressing regional collection and distribution challenges. Canada and the United States combine sophisticated research, clinical demand, and established regulatory systems. China and India are expanding biopharmaceutical capabilities and working to improve supply independence. Japan and South Korea emphasize precision manufacturing and advanced quality control. In Europe, France, Germany, Italy, Spain, and the United Kingdom bring mature healthcare and regulatory ecosystems, with continued attention to donor availability, manufacturing resilience, and cross-border coordination. Russia’s operating environment is shaped by domestic production priorities, regulatory requirements, and logistics constraints.

Actions for Leaders Building Resilient Fractionation Capabilities

Industry leaders should diversify qualified plasma sources, strengthen donor-retention programs, and establish transparent traceability from collection through finished product. Investment should prioritize validated automation, flexible purification platforms, robust cold-chain monitoring, and analytical systems that detect deviations early. Organizations should also develop clear AI-governance frameworks, conduct cybersecurity and model-risk reviews, and maintain skilled technical teams. Partnerships with hospitals, regulators, research institutions, and public-health authorities can improve demand visibility, emergency preparedness, and responsible access while supporting compliance and public trust.

Methodology for the Executive Summary

This summary uses the defined market scope of blood plasma fractionation technology and organizes the assessment across technology, operational, regulatory, regional, group, and country dimensions. Insights are framed from established characteristics of plasma-derived therapeutics, bioprocessing, healthcare infrastructure, and supply-chain management. The analysis intentionally excludes market estimates, market shares, forecasts, and company-specific claims. Regional and country observations are qualitative and should be validated against current legislation, official health data, regulatory publications, and facility-level evidence before investment or policy decisions.

Conclusion: Resilience, Quality, and Responsible Innovation

Blood plasma fractionation technology is advancing through the combined influence of bioprocess innovation, stronger quality systems, digital operations, and growing attention to supply security. The most durable progress will come from integrating scientific rigor with ethical donation practices, reliable infrastructure, regulatory cooperation, and disciplined adoption of AI. Leaders that build transparent, adaptable, and patient-centered operating models will be better positioned to support consistent access to plasma-derived therapies across diverse healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Plasma Fractionation Technology Market, by Fractionation Method
7.1. Introduction
7.2. Chromatography
7.3. Cold Ethanol Fractionation
7.4. Membrane Filtration
7.4.1. Diafiltration
7.4.2. Microfiltration
7.4.3. Ultrafiltration
7.5. Nanofiltration
7.6. Pasteurization
7.7. Precipitation
7.7.1. Ammonium Sulfate Precipitation
7.7.2. Caprylate Precipitation
7.7.3. Polyethylene Glycol Precipitation
7.8. Solvent Detergent Treatment
8. Blood Plasma Fractionation Technology Market, by Product Type
8.1. Introduction
8.2. Albumin
8.3. Coagulation Factors
8.4. Diagnostic Reagents
8.5. Hyperimmune Globulins
8.6. Immunoglobulins
8.7. Plasma Derived Medicinal Products
9. Blood Plasma Fractionation Technology Market, by Process Stage
9.1. Introduction
9.2. Downstream
9.3. Fractionation
9.4. Plasma Collection
9.5. Pooling
9.6. Pre Treatment
9.7. Quality Control
9.8. Storage And Distribution
10. Blood Plasma Fractionation Technology Market, by Purification Technique
10.1. Introduction
10.2. Affinity Separation
10.3. Chromatographic Purification
10.4. Membrane Technologies
10.5. Nanofiltration And Virus Clearance
10.6. Precipitative Purification
11. Blood Plasma Fractionation Technology Market, by Automation Level
11.1. Introduction
11.2. Fully Automated
11.3. Integrated Digital Manufacturing
11.4. Manual
11.5. Semi Automated
12. Blood Plasma Fractionation Technology Market, by End User
12.1. Introduction
12.2. Blood Centers
12.3. Clinical Laboratories
12.4. Contract Manufacturing Organizations
12.5. Hospitals
12.6. Pharmaceutical Companies
12.7. Plasma Fractionators
12.8. Research Institutes
13. Blood Plasma Fractionation Technology Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Blood Plasma Fractionation Technology Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Blood Plasma Fractionation Technology Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. ADMA Biologics, Inc.
17.2. Bio Products Laboratory Ltd
17.3. Biotest AG
17.4. CSL Limited
17.5. Grifols, S.A.
17.6. Intas Pharmaceuticals Ltd.
17.7. Kedrion S.p.A.
17.8. LFB S.A.
17.9. Octapharma AG
17.10. Shandong RAAS Blood Products Co., Ltd.
17.11. Takeda Pharmaceutical Company Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Blood Plasma Fractionation Technology Market, Years Considered for the Study
FIGURE 2. Global Blood Plasma Fractionation Technology Market, Research Design
FIGURE 3. Global Blood Plasma Fractionation Technology Market, Research Framework
FIGURE 4. Global Blood Plasma Fractionation Technology Market, Data Triangulation
FIGURE 5. Global Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2025 vs 2032 (%)
FIGURE 7. Global Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Blood Plasma Fractionation Technology Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Blood Plasma Fractionation Technology Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Blood Plasma Fractionation Technology Market Size, by Process Stage, 2025 vs 2032 (%)
FIGURE 11. Global Blood Plasma Fractionation Technology Market Size, by Process Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2025 vs 2032 (%)
FIGURE 13. Global Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Blood Plasma Fractionation Technology Market Size, by Automation Level, 2025 vs 2032 (%)
FIGURE 15. Global Blood Plasma Fractionation Technology Market Size, by Automation Level, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Blood Plasma Fractionation Technology Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Blood Plasma Fractionation Technology Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Blood Plasma Fractionation Technology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Blood Plasma Fractionation Technology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Blood Plasma Fractionation Technology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Blood Plasma Fractionation Technology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Blood Plasma Fractionation Technology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Blood Plasma Fractionation Technology Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Blood Plasma Fractionation Technology Market Segmentation & Coverage
TABLE 2. Global Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 3. Global Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 4. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cold Ethanol Fractionation Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cold Ethanol Fractionation Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cold Ethanol Fractionation Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Membrane Filtration Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Membrane Filtration Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Membrane Filtration Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Diafiltration Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Diafiltration Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Diafiltration Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Microfiltration Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Microfiltration Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Microfiltration Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Ultrafiltration Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Ultrafiltration Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Ultrafiltration Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Nanofiltration Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Nanofiltration Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Nanofiltration Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Pasteurization Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Pasteurization Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Pasteurization Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Precipitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Precipitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Precipitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Ammonium Sulfate Precipitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Ammonium Sulfate Precipitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Ammonium Sulfate Precipitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Caprylate Precipitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Caprylate Precipitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Caprylate Precipitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Polyethylene Glycol Precipitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Polyethylene Glycol Precipitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Polyethylene Glycol Precipitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Solvent Detergent Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Solvent Detergent Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Solvent Detergent Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 44. Global Albumin Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Albumin Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Albumin Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Coagulation Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Coagulation Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Coagulation Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Diagnostic Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Diagnostic Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hyperimmune Globulins Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hyperimmune Globulins Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hyperimmune Globulins Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Immunoglobulins Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Immunoglobulins Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Immunoglobulins Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Plasma Derived Medicinal Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Plasma Derived Medicinal Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Plasma Derived Medicinal Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 63. Global Downstream Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Downstream Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Downstream Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Fractionation Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Fractionation Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Fractionation Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Plasma Collection Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Plasma Collection Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Plasma Collection Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Pooling Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Pooling Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Pooling Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Pre Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Pre Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Pre Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Quality Control Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Quality Control Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Quality Control Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Storage And Distribution Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Storage And Distribution Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Storage And Distribution Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 85. Global Affinity Separation Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Affinity Separation Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Affinity Separation Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Chromatographic Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Chromatographic Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Chromatographic Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Membrane Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Membrane Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Membrane Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Nanofiltration And Virus Clearance Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Nanofiltration And Virus Clearance Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Nanofiltration And Virus Clearance Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Precipitative Purification Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Precipitative Purification Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Precipitative Purification Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 101. Global Fully Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Fully Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Fully Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Integrated Digital Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Integrated Digital Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Integrated Digital Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Manual Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Manual Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Manual Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Semi Automated Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Semi Automated Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Semi Automated Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Global Blood Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Blood Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Blood Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Plasma Fractionators Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Plasma Fractionators Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Plasma Fractionators Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. North America Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. North America Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 147. North America Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 148. North America Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 149. North America Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. North America Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 151. North America Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 152. North America Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 153. North America Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Latin America Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Latin America Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 156. Latin America Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 157. Latin America Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 158. Latin America Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 159. Latin America Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 160. Latin America Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 161. Latin America Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 162. Latin America Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Europe Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Europe Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 165. Europe Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 166. Europe Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 167. Europe Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Europe Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 169. Europe Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 170. Europe Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 171. Europe Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Middle East Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Middle East Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 174. Middle East Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 175. Middle East Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 176. Middle East Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Middle East Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 178. Middle East Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 179. Middle East Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 180. Middle East Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Africa Blood Plasma Fractionation Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Africa Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 183. Africa Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 184. Africa Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 185. Africa Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Africa Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 187. Africa Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 188. Africa Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 189. Africa Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Global Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. ASEAN Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. ASEAN Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 193. ASEAN Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 194. ASEAN Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 195. ASEAN Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. ASEAN Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 197. ASEAN Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 198. ASEAN Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 199. ASEAN Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. GCC Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. GCC Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 202. GCC Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 203. GCC Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 204. GCC Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 205. GCC Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 206. GCC Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 207. GCC Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 208. GCC Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. European Union Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. European Union Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 211. European Union Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 212. European Union Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 213. European Union Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. European Union Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 215. European Union Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 216. European Union Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 217. European Union Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. BRICS Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. BRICS Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 220. BRICS Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 221. BRICS Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 222. BRICS Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. BRICS Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 224. BRICS Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 225. BRICS Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 226. BRICS Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. G7 Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. G7 Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 229. G7 Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 230. G7 Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 231. G7 Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. G7 Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 233. G7 Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 234. G7 Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 235. G7 Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. NATO Blood Plasma Fractionation Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. NATO Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 238. NATO Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 239. NATO Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 240. NATO Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. NATO Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 242. NATO Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 243. NATO Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 244. NATO Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Global Blood Plasma Fractionation Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 246. United States Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 247. United States Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 248. United States Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 249. United States Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 250. United States Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. United States Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 252. United States Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 253. United States Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 254. United States Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Canada Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 256. Canada Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 257. Canada Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 258. Canada Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 259. Canada Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. Canada Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 261. Canada Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 262. Canada Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 263. Canada Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Mexico Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 265. Mexico Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 266. Mexico Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 267. Mexico Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 268. Mexico Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. Mexico Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 270. Mexico Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 271. Mexico Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 272. Mexico Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 273. Brazil Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 274. Brazil Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 275. Brazil Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 276. Brazil Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 277. Brazil Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Brazil Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 279. Brazil Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 280. Brazil Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 281. Brazil Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. United Kingdom Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 283. United Kingdom Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 284. United Kingdom Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 285. United Kingdom Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 286. United Kingdom Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. United Kingdom Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 288. United Kingdom Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 289. United Kingdom Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 290. United Kingdom Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Germany Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 292. Germany Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 293. Germany Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 294. Germany Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 295. Germany Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Germany Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 297. Germany Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 298. Germany Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 299. Germany Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. France Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 301. France Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 302. France Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 303. France Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 304. France Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. France Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 306. France Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 307. France Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 308. France Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 309. Russia Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 310. Russia Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 311. Russia Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 312. Russia Blood Plasma Fractionation Technology Market Size, by Precipitation, 2017-2032 (USD Million)
TABLE 313. Russia Blood Plasma Fractionation Technology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. Russia Blood Plasma Fractionation Technology Market Size, by Process Stage, 2017-2032 (USD Million)
TABLE 315. Russia Blood Plasma Fractionation Technology Market Size, by Purification Technique, 2017-2032 (USD Million)
TABLE 316. Russia Blood Plasma Fractionation Technology Market Size, by Automation Level, 2017-2032 (USD Million)
TABLE 317. Russia Blood Plasma Fractionation Technology Market Size, by End User, 2017-2032 (USD Million)
TABLE 318. Italy Blood Plasma Fractionation Technology Market Size, 2017-2032 (USD Million)
TABLE 319. Italy Blood Plasma Fractionation Technology Market Size, by Fractionation Method, 2017-2032 (USD Million)
TABLE 320. Italy Blood Plasma Fractionation Technology Market Size, by Membrane Filtration, 2017-2032 (USD Million)
TABLE 321. Italy Blood Plasma Fractionation Techn

Companies Mentioned

  • ADMA Biologics, Inc.
  • Bio Products Laboratory Ltd
  • Biotest AG
  • CSL Limited
  • Grifols, S.A.
  • Intas Pharmaceuticals Ltd.
  • Kedrion S.p.A.
  • LFB S.A.
  • Octapharma AG
  • Shandong RAAS Blood Products Co., Ltd.
  • Takeda Pharmaceutical Company Limited